生育治疗服务市场规模、份额和成长分析(按手术、服务、最终用户和地区划分)-2026-2033年产业预测
市场调查报告书
商品编码
1902486

生育治疗服务市场规模、份额和成长分析(按手术、服务、最终用户和地区划分)-2026-2033年产业预测

Fertility Services Market Size, Share, and Growth Analysis, By Procedure (IVF with ICSI, IVF without ICSI), By Service (Fresh Non-Donor, Frozen Non-Donor), By End User, By Region -Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 196 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到 2024 年,不孕症治疗服务市场规模将达到 477.4 亿美元,到 2025 年将达到 519.9 亿美元,到 2033 年将达到 1028.4 亿美元,预测期(2026-2033 年)的复合年增长率为 8.9%。

市场趋势分析显示,受社会规范变化的影响,对生育治疗服务的需求显着成长。由于越来越多的女性因事业或个人原因而延迟生育,初次生育的平均年龄不断上升,导致不孕率上升。研究表明,这一趋势在已开发国家尤其明显,许多女性面临自然受孕困难。因此,随着夫妻寻求有效解决生育难题的途径,对辅助生殖技术(ART)的需求明显增加。生活方式选择与生物因素之间的复杂相互作用,进一步加剧了对各种辅助生殖技术服务的需求。随着社会动态的不断演变,生育治疗服务市场预计将持续成长,以满足未来父母日益增长的需求。

生育治疗服务市场的成长要素

生育服务市场的成长主要受不孕症上升的驱动,而不孕不育的成因包括压力增加、生育计画延迟、生活方式改变等。此外,肥胖、吸烟等健康问题以及环境毒素暴露也加剧了许多人的生殖健康挑战。为了满足日益增长的有效解决方案需求,辅助生殖技术(ART)的进步显着提高了现有治疗的品质和有效性,为渴望生育的人们带来了希望。这种不断变化的市场格局凸显了提供全面生育服务以应对复杂生殖健康问题的迫切需求。

生育治疗服务市场的限制

生育服务市场面临许多限制因素,这些限制因素源自于与生殖技术相关的道德和法律挑战。胚胎冷冻、代孕和卵子捐赠等程序在不同地区常常遭遇宗教和文化上的反对。此外,各国不同的法律体制也构成障碍,限制了人们获得这些治疗的机会,阻碍了辅助生殖技术的广泛应用。这些差异不仅影响寻求生育治疗的个人,也导致市场格局分散,使得服务提供者难以应对在全球范围内提供服务的复杂性。

不孕症治疗服务的市场趋势

生育服务市场正经历一个显着的趋势:生育力保存技术的普及率不断提高,尤其是在千禧世代和麵临健康挑战的人群中。随着越来越多的人出于个人、职业和健康原因推迟生育,对卵子和精子冷冻保存等服务的需求也随之激增。这种转变推动了冷冻保存技术的进步,并有助于提高人们获得生殖健康服务的机会。此外,辅助生殖技术的社会接受度不断提高,也为寻求这些服务的个人创造了有利的环境,最终促进了生育服务产业的蓬勃发展和创新。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数(2025)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 案例研究
  • 监管环境

全球不孕症治疗服务市场规模(按类型及复合年增长率划分)(2026-2033 年)

  • 诊断
  • 治疗
  • 保持

全球不孕症治疗服务市场规模(依治疗项目及复合年增长率划分)(2026-2033 年)

  • 体外受精(IVF)结合卵胞浆内单一精子注射(ICSI)
  • 子宫内人工授精(IUI)
  • 体外受精(IVF)无需卵胞浆内单一精子注射(ICSI)。
  • 代孕
  • 其他治疗方法

全球不孕症治疗服务市场规模(按服务类型划分)及复合年增长率(2026-2033 年)

  • 新鲜非提供者
  • 冷冻非捐赠者
  • 卵子和胚胎库
  • 新捐赠者
  • 冷冻捐赠者

全球不孕症治疗服务市场规模(依最终用户划分)及复合年增长率(2026-2033 年)

  • 不孕不育诊所
  • 医院
  • 手术中心
  • 临床研究所

全球不孕症治疗服务市场规模及复合年增长率(2026-2033)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位(2025 年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析(2025 年)
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Merck KGaA(Germany)
  • Vitrolife AB(Sweden)
  • Monash IVF Group(Australia)
  • Genea Limited(Australia)
  • Progyny, Inc.(United States)
  • Ferring Pharmaceuticals(Switzerland)
  • CooperSurgical, Inc.(United States)
  • Cook Medical Inc.(United States)
  • The Cooper Companies, Inc.(United States)
  • Virtus Health(Australia)
  • Cryos International(Denmark)
  • Carolinas Fertility Institute(United States)
  • Apollo Fertility(India)
  • Bloom IVF Centre(India)
  • Bangkok IVF Center(Thailand)
  • Medicover Fertility(Sweden)

结论与建议

简介目录
Product Code: SQMIG35D2292

Fertility Services Market size was valued at USD 47.74 Billion in 2024 and is poised to grow from USD 51.99 Billion in 2025 to USD 102.84 Billion by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).

Market insights reveal a notable surge in the demand for fertility services, driven by shifts in societal norms. With women increasingly delaying motherhood for career advancements and personal goals, the median age for first-time mothers has risen, contributing to heightened infertility rates. Studies indicate this trend is particularly evident in developed countries, where many women are experiencing difficulties in conceiving naturally. Consequently, the rising demand for Assisted Reproductive Technology (ART) is evident, as couples seek effective solutions for conception challenges. The complex interplay of lifestyle choices and biological factors amplifies the necessity for a diverse range of ART services. As societal dynamics continue to evolve, the fertility services market is poised for sustained growth to meet the burgeoning needs of prospective parents.

Top-down and bottom-up approaches were used to estimate and validate the size of the Fertility Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Fertility Services Market Segments Analysis

Global Fertility Services Market is segmented by Type, Procedure, Service, End-User and region. Based on Type, the market is segmented into Diagnosis, Treatment and Preservation. Based on Procedure, the market is segmented into In Vitro Fertilization (IVF) with Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), IVF without ICSI, Surrogacy and Other Procedures. Based on Service, the market is segmented into Fresh Non-donor, Frozen Non-donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor. Based on End-User, the market is segmented into Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Fertility Services Market

The growth of the fertility services market is largely attributed to rising infertility rates influenced by factors such as heightened stress levels, delayed family planning, and changing lifestyles. Furthermore, health issues like obesity and smoking, along with exposure to environmental toxins, have increased reproductive health challenges for many individuals. In response to this growing demand for effective solutions, advancements in assisted reproductive technology (ART) have significantly enhanced the quality and effectiveness of treatments available, providing hope to those seeking to conceive. This evolving landscape underscores the urgent need for comprehensive fertility services to address the complexities surrounding reproductive health.

Restraints in the Fertility Services Market

The Fertility Services market faces several constraints rooted in moral and legal challenges associated with reproductive technologies. Practices such as embryo freezing, surrogacy, and egg donation often encounter significant religious and cultural opposition in various regions. Additionally, varying legal frameworks across countries can create barriers that limit access to these treatments, hindering the widespread acceptance of assisted reproductive technologies. Such disparities not only impact individuals seeking fertility assistance but also contribute to a fragmented market landscape, making it difficult for providers to navigate the complexities of offering services in a global context.

Market Trends of the Fertility Services Market

The fertility services market is witnessing a significant trend driven by the rising adoption of fertility preservation techniques, particularly among millennials and individuals facing medical challenges. As more people delay parenthood for personal, professional, or health-related reasons, the demand for services such as egg and sperm freezing is surging. This shift is catalyzing advancements in cryopreservation technologies and enhancing overall accessibility to fertility options. Additionally, the cultural acceptance of assisted reproductive technologies is fostering a supportive environment for individuals seeking these services, ultimately contributing to robust growth and innovation in the fertility services sector.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape

Global Fertility Services Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Diagnosis
  • Treatment
  • Preservation

Global Fertility Services Market Size by Procedure & CAGR (2026-2033)

  • Market Overview
  • In Vitro Fertilization (IVF) with Intracytoplasmic Sperm Injection (ICSI)
  • Intrauterine Insemination (IUI)
  • IVF without ICSI
  • Surrogacy
  • Other Procedures

Global Fertility Services Market Size by Service & CAGR (2026-2033)

  • Market Overview
  • Fresh Non-donor
  • Frozen Non-donor
  • Egg & Embryo Banking
  • Fresh Donor
  • Frozen Donor

Global Fertility Services Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes

Global Fertility Services Market Size & CAGR (2026-2033)

  • North America (Type, Procedure, Service, End-User)
    • US
    • Canada
  • Europe (Type, Procedure, Service, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Procedure, Service, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Procedure, Service, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Procedure, Service, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vitrolife AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Monash IVF Group (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genea Limited (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Progyny, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ferring Pharmaceuticals (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CooperSurgical, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • The Cooper Companies, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Virtus Health (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cryos International (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Carolinas Fertility Institute (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Apollo Fertility (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bloom IVF Centre (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bangkok IVF Center (Thailand)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medicover Fertility (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations